Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study

Circulation

Volumn 90, Issue 2, 1994, Pages 928-936

  Marcus, Roy ^a   Krause, Lisa ^a   Weder, Alan B ^a,b   Dominguez Mejia, Agnes ^a   Schork, Nicholas J ^a   Julius, Stevo ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

insulin; nervous system; norepinephrine; obesity

Indexed keywords

INSULIN; NORADRENALIN; TRIACYLGLYCEROL;

ADRENERGIC SYSTEM; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; M MODE ECHOCARDIOGRAPHY; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

EID: 0027964642     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.90.2.928     Document Type: Article

References (57)

1. Kannel WB, Dawber TR, Kagan A, Retotskie N, Stokes J III. Factors of risk in the development of coronary heart disease: six year follow-up experience: the Framingham Study. Ann Intern Med. 1961;55:33-50.
2. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence and mortality in the Framingham Study. Ann Intern Med. 1969;71:89-105.
3. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and the risk of coronary heart disease: the Framingham Study. Ann Intern Med. 1970;72:813-822.
4. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1983;75(suppl 3A):4-11.
5. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981;63:1391-1398.
6. Woythaler JN, Singer SL, Kwan OL, Meltzer RS, Reubner B, Bommer W, DeMaria A. Accuracy of echocardiography vs electrocardiography in detecting left ventricular hypertrophy. J Am Coll Cardiol. 1983;2:305-311.
7. Devereux RB, Casale PN, Wallerson DC, Klingfield P, Hammond IW, Liebson PR, Campo E, Alonso DR, Laragh JH. Costeffectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension. 1987;9(suppl II):II-69-II-76.
8. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH. Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105: 173-178.
9. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Study. Ann Intern Med. 1989;110: 101-107.
10. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study. N Engl J Med. 1990;322: 1561-1566.
11. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study. Ann Intern Med. 1988;108:7-13.
12. Savage DD, Levy D, Dannenberg AL, Garrison RJ, Castelli WP. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity: the Framingham Study. Am J Cardiol. 1990;65:371-376.
13. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol. 1988;12:996-1004.
14. Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1993;87:476-486.
15. Daniels SD, Meyer RA, Loggie JMH. Determinants of cardiac involvement in children and adolescents with essential hypertension. Circulation. 1990;82:1243-1248.
16. Goble MM, Mosteller M, Moskowitz WB, Schicken RM. Sex differences in the determinants of left ventricular mass in childhood: the Medical College of Virginia twin study. Circulation. 1992;85: 1661-1665.
17. Julius S, Mejia A, Jones K, Krause L, Schork NJ, van de Ven C, Johnson EH, Petrin J, Sekkarie MA, Kjeldsen SE, Schmouder R, Gupta R, Ferraro J, Nazzaro P, Weisfield J. White coat versus sustained borderline hypertension in Tecumseh, Michigan. Hypertension. 1990;16:617-623.
18. Julius S, Krause L, Schork NJ, Mejia AD, Jones KA, van de Nen C, Johnson EH, Sekkarie MA, Kjeldsen SE, Petrin J. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens. 1991; 9:77-84.
19. Julius S, Jamerson K, Mejia AD, Krause L, Schork NJ, Jones KA. The association of borderline hypertension with target organ changes and higher coronary risk: Tecumseh blood pressure study. JAMA. 1990;264:354-358.
20. Meija AD, Julius S, Jones KA, Schork NJ, Kneisley J. The Tecumseh blood pressure study: normative data on blood pressure self-determination. Arch Intern Med. 1990;150:1209-1213.
21. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomical validation of the method. Circulation. 1977;55:613-618.
22. Dubois D, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863-871.
23. Metropolitan Life Insurance Company. New weight standards for men and women. Stat Bull. 1959;40:1-4.
24. Durnin JVGA, Rahaman MM. The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr. 1967;21:681-689.
25. Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977;21:625-636.
26. Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin 1 to the physiologic measurement of plasma renin activity in normal healthy subjects. J Clin Endocrinol Metab. 1969;29:1349-1355.
27. Hayashi, Floyd JC Jr, Pek S, Fajans SS. Insulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism. J Clin Endocrinol Metab. 1977;44:681-694.
28. Hinderliter AL, Light KC, Willis PW IV. Gender differences in left ventricular structure and function in young adults with normal or marginally elevated blood pressure. Am J Hypertens. 1992;5:32-36.
29. Savage DD, Garrison RJ, Kennel WB, Levy D, Anderson SJ, Stokes J, Feinlieb M, Castelli WP. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation. 1987;75(suppl I):I-26-I-33.
30. Devereux RB, Lutus EM, Casale PN, Klingfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984;4:1222-1230.
31. Weder AB, Schork NJ, Krause L, Julius S. Red blood cell lithium-sodium countertransport in the Tecumseh blood pressure study. Hypertension. 1991;17:652-660.
32. White WB, Schulman P, McCabea EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA. 1989;261:873-877.
33. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells in an alpha, adrenergic response. J Clin Invest. 1983;72:732-738.
34. 1-adrenergic receptor interaction. Circ Res. 1985;56:884-894.
35. Laks MM, Morady F, Swan HJC. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest. 1973;64:75-78.
36. Julius S, Li Y, Brant D, Krause L, Buda AJ. Neurogenic presser episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension. 1989;13:422-429.
37. Yamori Y, Mori C, Nishio T, Ooshima A, Horie R, Ohtaka M, Soeda T, Saito M, Abe K, Nara Y, Nakao Y, Kihara M. Cardiac hypertrophy in early hypertension. Am J Cardiol. 1979;44:964-969.
38. Sen S, Tarazi RC, Khairallah PA, Bumpus FM. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res. 1974;35: 775-781.
39. Pfeffer MA, Pfeffer JM. Pharmacologic regression of cardiac hypertrophy in experimental hypertension. J Cardiovasc Pharmacol. 1984; 6(suppl 6):S865-S869.
40. Hartford M, Wilkstrand J, Wallentin I, Ljungman S, Berglund G. The relation between cardiac hypertrophy and hypertension. Acta Med Scand Suppl. 1983;672:101-104.
41. Ferrara LA, Mancini M, de Simone G, Pisanti N, Capone D, Fasano ML, Mancini M. Adrenergic nervous system and left ventricular mass in primary hypertension. Eur Heart J. 1989;10: 1036-1040.
42. Fujita T, Noda H, Ito Y, Isaka M, Sato Y, Ogata E. Increased sympathoadrenomedullary activity and left ventricular hypertrophy in young patients with borderline hypertension. J Mol Cell Cardiol. 1989;21(suppl 5):31-38.
43. Corea L, Bentivoglio M, Verdecchia P, Motolese M. Left ventricular wall thickness and plasma catecholamines in borderline and stable essential hypertension. Eur Heart J. 1982;3:164-170.
44. Devereux RB, Pickering TG, Harshfield GA, Kleinen HD, Denby L, Clark L, Pregibon D, Jason M, Kleiner B, Borer JS, Laragh JH. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regular recurring stress. Circulation. 1983;68:470-476.
45. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:93-98.
46. Julius S, Randall OS, Esler MD, Kashima T, Ellis CN, Bennett J. Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension. Circ Res. 1975;36-37(suppl I):I-199-I-207.
47. Julius S, Gudbrandsson T, Jamerson K, Anderson O. The interconnection between sympathetics, microcirculation and insulin resistance in hypertension. Blood Pressure. 1992;1:9-19.
48. Defronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
49. Forgue ME, Freychet P. Insulin receptors in the heart muscle: demonstration of specific binding sites and impairment of insulin binding in the plasma membrane of the obese hyperglycemic mouse. Diabetes. 1975;24:715-723.
50. Endo F, Elsas LJ. Structural analysis and subunit interaction of insulin receptor from membrane of cultured embryonic chick heart cells. Endocrinology. 1984;115:1828-1837.
51. Fuller SJ, Mynett JR, Sugden PH. Stimulation of cardiac protein synthesis by insulin-like growth factors. Biochemistry. 1992;282: 85-90.
52. Pfeifle B, Ditschuneit H. Effect of insulin on the growth of cultured arterial smooth muscle cells. Diabetologia. 1981;20:155-158.
53. Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res. 1975;36:319-327.
54. Pfeifle B, Ditschuneit HH, Ditschuneit H. Insulin as a cellular growth regulator of rat arterial smooth muscle cells in vitro. Horm Metab Res. 1980;12:381-385.
55. King GL, Goodman D, Buzney S, Moses A, Kahn CR. Receptors and growth promoting effects of insulin and insulin like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest. 1985;75:1028-1036.
56. Kaiser N, Tur-Sinai A, Hasin M, Cerasi E. Binding, degradation and biological activity of insulin in vascular smooth muscle cells. Am J Physiol. 1985;249:E292-E298.
57. Cruz AB, Amatuzio DS, Grande F, Hay LJ. Effect of intraarterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res. 1961;9:39-43.